NatWest Group PLC (RYSD)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 7.496 |
|---|---|
| 52-week range | 5.870 – 8.462 |
| Return, 1 month / 3 months | −5.5% / −2.7% |
| Return, 1 year / 3 years | +26.4% / +264.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 38 |
| Volatility (1 year) | 28.9% |
| Worst drawdown (1 year) | -21.6% |
| Average daily value traded | 0.54M EUR |
| Dividend yield | 6.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NatWest Group is a British banking group based in Edinburgh that serves personal, business and commercial customers. Through brands such as NatWest, Royal Bank of Scotland and Ulster Bank, it offers current and savings accounts, mortgages, loans, credit cards, insurance and payment services to households, while also providing lending, cash management and financing to companies and larger corporate clients. It operates mainly across the United Kingdom and Ireland.
The shares are listed on the XETRA Stock Exchange in Germany under the code RYSD, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NatWest Group PLC (RYSD) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 7.496 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 103 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.4% and over the last three months it fell 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 3.6% | ||
| From 52-week high | -10.8% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.7% | ||
| 6-month return | 12.7% | ||
| 12-month return, skipping the last month | 33.8% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.6% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.54M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.1% |
|---|---|
| 1 month | −5.5% |
| 3 months | −2.7% |
| 6 months | +12.7% |
| 1 year | +26.4% |
| 3 years | +264.8% |
| 5 years | +272.6% |
Signals
| 50-day / 200-day average | 7.949 / 7.232 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.170 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.1423 |
| 19 Mar 2026 | GBP 0.2726 |
| 7 Aug 2025 | GBP 0.1126 |
| 13 Mar 2025 | GBP 0.1837 |
| 8 Aug 2024 | GBP 0.0711 |
| 14 Mar 2024 | GBP 0.1363 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.